Research output per year
Research output per year
Research activity per year
Dr. Cathy Xie is a research fellow at the Australian Translational Medicinal Chemistry Facility (ATMCF) in Monash Institute of Pharmaceutical Sciences (MIPS). Her current project is in partnership with the Australian largest radiopharmaceutical company - Cyclotek, aiming at developing novel 18F-labelled radiotracers for PET imaging, as new and better diagnostics of various human cancers with potential in clinic application.
Cathy has a long-term research focus on drug discovery. She received her doctorate degree in Medicinal Chemistry from Monash University in 2020. Her PhD project is about developing novel GSTO1-1 inhibitors for the treatment of inflammatory conditions.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Medicinal Chemistry, Doctor of Philosophy, Development of GSTO1-1 inhibitors for the treatment of inflammatory conditions, MONASH UNIVERSITY
30 Sept 2016 → 2 Apr 2020
Award Date: 2 Apr 2020
Pharmaceutical Sciences, Bachelor of Science, China Pharmaceutical University
1 Sept 2012 → 30 Jun 2016
Award Date: 30 Jun 2016
Research output: Contribution to journal › Article › Research › peer-review
Research output: Contribution to journal › Article › Research › peer-review
Research output: Contribution to journal › Article › Research › peer-review
Research output: Contribution to journal › Review Article › Research › peer-review
Research output: Contribution to journal › Article › Research › peer-review